Senate BillIntroduced
S 5352: Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product; requires both oral and written notification.
What S 5352 does, verified January 8, 2026
The bill aims to improve patient care by requiring healthcare providers to inform patients when they substitute one generic drug product for another. This notification must be provided both in writing and orally to the patient. The goal is to ensure patients are aware of any changes to their medication and can make informed decisions about their care. The changes will take effect after a certain period of time, allowing healthcare providers to implement the new requirement.
Bill journey
1IntroducedCurrent
2In CommitteePending
3First Chamber FloorPending
4Second ChamberPending
5GovernorPending
6ChapteredPending
Last action: REFERRED TO HIGHER EDUCATION (2026-01-07)Alert me
Quick answers about S 5352
- What is the current status of S 5352?
- As of January 8, 2026, S 5352 is recorded as "Introduced": it has been introduced and is waiting for its first committee hearing or floor vote. The last recorded action, on January 7, 2026, was "REFERRED TO HIGHER EDUCATION".
- Did S 5352 pass?
- Not yet. S 5352 has been introduced and has not passed either house.
- Who wrote S 5352, and where is it now?
- S 5352 was authored by Sen. Leroy Comrie. Its committee of record is Senate Higher Education.
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlockRecent actions2 total · showing 2
| Jan. 07, 2026 | REFERRED TO HIGHER EDUCATION |
| Feb. 20, 2025 | REFERRED TO HIGHER EDUCATION |
Latest bill textIntroduced version, February 20, 2025 · 197 words
STATE OF NEW YORK ________________________________________________________________________ 5352 2025-2026 Regular Sessions IN SENATE February 20, 2025 ___________ Introduced by Sen. COMRIE -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education AN ACT to amend the education law, in relation to notification of the substitution of one generic drug product for another generic drug The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision 6 of section 6810 of the education law is 2 amended by adding a new paragraph (b-1) to read as follows: 3 (b-1) The prescriber or pharmacist shall inform the patient whether 4 they have prescribed or substituted a different generic drug product 5 from the generic drug product the patient has previously received. 6 Notification required pursuant to this paragraph shall be provided both 7 written and orally. 8 § 2. This act shall take effect on the ninetieth day after it shall 9 have become a law. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD09499-01-5
Text of S 5352 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions